跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,780 条关于
“pneumococcal bacteremia”
全部
1,780
临床试验
1,481
药物
150
机构
2
资讯
147
去年
Merck's CAPVAXIVE Shows Superior Immune Response in High-Risk Children and Adolescents
去年
Merck's CAPVAXIVE Receives Positive EU CHMP Opinion for Pneumococcal Vaccine
去年
Pneumococcal Disease Pipeline Shows Strong Growth with 20+ Therapies in Development
2年前
FDA Approves Merck's CAPVAXIVE: First 21-Serotype Pneumococcal Vaccine Designed Specifically for Adults
2年前
Vaxcyte's VAX-31 Demonstrates Positive Phase 1/2 Results, Advancing to Phase 3 for Pneumococcal Disease
9个月前
Saskatchewan Adds Merck's CAPVAXIVE to Publicly Funded Adult Immunization Program
去年
Vaxcyte's VAX-24 Shows Promising Results Despite Phase 2 Serotype Misses in Infant Study
去年
Merck's CAPVAXIVE Shows Promise Against Pneumococcal Disease in Adults
去年
Armata's Bacteriophage Therapy Shows Promising Results in Treating Staphylococcus aureus Bacteremia
去年
FDA Approves Capvaxive, First Adult-Specific 21-Valent Pneumococcal Vaccine
第 1 页,共 15 页
上一页
下一页